Steven Cohen's LFCR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 15,656 shares of Lifecore Biomedical, Inc. (LFCR) worth $128,066, representing 0.00% of the portfolio. First purchased in 2021-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in LFCR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2022, adding 84,537 shares. Largest reduction occurred in Q1 2023, reducing 141,446 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Lifecore Biomedical (LFCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lifecore Biomedical (LFCR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +15,656 | New Buy | 15,656 | $8.18 |
| Q1 2023 | -141,446 | Sold Out | 0 | $0.00 |
| Q4 2022 | -44,758 | Reduce 24.04% | 141,446 | $6.48 |
| Q3 2022 | -17,496 | Reduce 8.59% | 186,204 | $8.89 |
| Q2 2022 | -57,856 | Reduce 22.12% | 203,700 | $9.97 |
| Q1 2022 | +84,537 | Add 47.76% | 261,556 | $11.58 |
| Q4 2021 | +177,019 | New Buy | 177,019 | $11.10 |
Steven Cohen's Lifecore Biomedical Investment FAQs
Steven Cohen first purchased Lifecore Biomedical, Inc. (LFCR) in Q4 2021, acquiring 177,019 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Lifecore Biomedical, Inc. (LFCR) for 7 quarters since Q4 2021.
Steven Cohen's largest addition to Lifecore Biomedical, Inc. (LFCR) was in Q4 2021, adding 177,019 shares worth $1.96 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 15,656 shares of Lifecore Biomedical, Inc. (LFCR), valued at approximately $128,066.
As of the Q4 2025 filing, Lifecore Biomedical, Inc. (LFCR) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Lifecore Biomedical, Inc. (LFCR) was 261,556 shares, as reported at the end of Q1 2022.